AARD - Aardvark Therapeutics, Inc.
7.02
-0.770 -10.969%
Share volume: 65,445
Last Updated: 04-10-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$7.79
-0.77
-0.10%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
-11.59%
1 Month
-32.63%
3 Months
-50.94%
6 Months
-50.94%
1 Year
-50.94%
2 Year
-50.94%
Key data
Stock price
$7.02
DAY RANGE
$6.51 - $7.82
52 WEEK RANGE
$4.88 - $19.58
52 WEEK CHANGE
-$50.94
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Tien-Li Lee
Region: US
Website: aardvarktherapeutics.com
Employees: 18
IPO year: 2025
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: aardvarktherapeutics.com
Employees: 18
IPO year: 2025
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We were incorporated in Delaware on May 17, 2017. Our principal executive offices are located at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA. We have one wholly-owned subsidiary, Artisan Therapeutics, Inc., incorporated in Delaware in October 2024.
Recent news
